Department of Paediatric Otolaryngology, Royal Hospital for Children, Glasgow, United Kingdom.
Department of Paediatric Otolaryngology, Royal Hospital for Children, Glasgow, United Kingdom.
Int J Pediatr Otorhinolaryngol. 2021 Jan;140:110492. doi: 10.1016/j.ijporl.2020.110492. Epub 2020 Nov 11.
This study aims to present a case series and systematic review of acute isolated sphenoid sinusitis (AISS) in children in order to better characterize clinical presentation, diagnosis, treatment, and outcomes of this condition.
Ovid MEDLINE, Pubmed, Embase, Cochrane Library, and Google Scholar.
Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Full-text, peer-reviewed journal publications from 1994 to 2020 in English; focus on acute sphenoid sinusitis; pediatric patients (<18 years of age); series with two or more children. Studies were assessed for data including demographics, presenting symptoms and signs, radiological investigations, treatment, outcomes and complications.
Ten studies identifying 71 patients were included. Average age at presentation was 12.0 years (range 5-17 years). M:F ratio 1:1. The most common presenting symptoms were headache (98.6%), fever (50.7%), nasal symptoms (22.5%) ocular symptoms (19.7%) and decreased level of consciousness (12.7%). Twenty patients (28.1%) had neurological signs. Twenty-three patients (32.4%) presented with headache in isolation. Unsuspected diagnosis at presentation was noted in 54.0%. Average time to initial presentation was 14.0 days (median = 5.5 days, range 1-90 days). The majority of children were treated with antibiotics (98.6%) with 31.0%, 2.8% and 2.8% also undergoing sinus surgery, revision sinus surgery and neurosurgery, respectively. Intracranial complications occurred in 16.9% of patients. Significant long term sequelae occurred in 2 children (2.8%) and one death (1.4%) was also reported.
All studies were retrospective case note reviews.
Acute sphenoid sinusitis is a rare and difficult condition to diagnose in children. The majority of patients make a full recovery with appropriate treatment. If treatment is delayed however consequences can be life-threatening.
本研究旨在通过病例系列和系统回顾,更好地描述儿童急性孤立性蝶窦炎(AISS)的临床表现、诊断、治疗和结局。
Ovid MEDLINE、Pubmed、Embase、Cochrane 图书馆和 Google Scholar。
系统评价和荟萃分析首选报告项目的指南。1994 年至 2020 年期间发表的全文同行评审期刊出版物,以英文发表;重点为急性蝶窦炎;儿科患者(<18 岁);包含两个或更多儿童的系列研究。评估研究数据包括人口统计学资料、主要症状和体征、影像学检查、治疗、结局和并发症。
纳入了 10 项研究,共 71 例患者。发病时的平均年龄为 12.0 岁(范围 5-17 岁)。男:女比例为 1:1。最常见的主要症状是头痛(98.6%)、发热(50.7%)、鼻部症状(22.5%)、眼部症状(19.7%)和意识水平下降(12.7%)。20 例(28.1%)有神经系统体征。23 例(32.4%)仅以头痛为首发症状。54.0%的患者在就诊时存在未被怀疑的诊断。首次就诊的平均时间为 14.0 天(中位数为 5.5 天,范围为 1-90 天)。大多数患儿接受抗生素治疗(98.6%),分别有 31.0%、2.8%和 2.8%的患儿接受鼻窦手术、鼻窦手术修正和神经外科手术。颅内并发症发生率为 16.9%。2 例(2.8%)患儿发生严重长期后遗症,1 例(1.4%)患儿死亡。
所有研究均为回顾性病历回顾。
急性孤立性蝶窦炎是一种罕见且难以诊断的儿童疾病。大多数患者经适当治疗后可完全康复。然而,如果治疗延迟,后果可能会危及生命。